Copyright Reports & Markets. All rights reserved.

Global Suvorexant Tablet Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Suvorexant Tablet Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 5 mg Tablets
    • 1.3.3 10 mg Tablets
    • 1.3.4 15 mg Tablets
    • 1.3.5 20 mg Tablets
    • 1.3.6 Other
  • 1.4 Market Analysis by Regulatory Status
    • 1.4.1 Overview: Global Suvorexant Tablet Consumption Value by Regulatory Status: 2021 Versus 2025 Versus 2032
    • 1.4.2 Approved Originator Product
    • 1.4.3 Approved Generic Product
    • 1.4.4 Generic Under Filing
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Suvorexant Tablet Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Sleep Onset Insomnia
    • 1.5.3 Sleep Maintenance Insomnia
    • 1.5.4 Mixed Insomnia
    • 1.5.5 Clinical Research
    • 1.5.6 Other
  • 1.6 Global Suvorexant Tablet Market Size & Forecast
    • 1.6.1 Global Suvorexant Tablet Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global Suvorexant Tablet Sales Quantity (2021-2032)
    • 1.6.3 Global Suvorexant Tablet Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck & Co.
    • 2.1.1 Merck & Co. Details
    • 2.1.2 Merck & Co. Major Business
    • 2.1.3 Merck & Co. Suvorexant Tablet Product and Services
    • 2.1.4 Merck & Co. Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck & Co. Recent Developments/Updates
  • 2.2 MSD K.K.
    • 2.2.1 MSD K.K. Details
    • 2.2.2 MSD K.K. Major Business
    • 2.2.3 MSD K.K. Suvorexant Tablet Product and Services
    • 2.2.4 MSD K.K. Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 MSD K.K. Recent Developments/Updates
  • 2.3 Merck Sharp & Dohme (Australia)
    • 2.3.1 Merck Sharp & Dohme (Australia) Details
    • 2.3.2 Merck Sharp & Dohme (Australia) Major Business
    • 2.3.3 Merck Sharp & Dohme (Australia) Suvorexant Tablet Product and Services
    • 2.3.4 Merck Sharp & Dohme (Australia) Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck Sharp & Dohme (Australia) Recent Developments/Updates
  • 2.4 Axplora Group
    • 2.4.1 Axplora Group Details
    • 2.4.2 Axplora Group Major Business
    • 2.4.3 Axplora Group Suvorexant Tablet Product and Services
    • 2.4.4 Axplora Group Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Axplora Group Recent Developments/Updates
  • 2.5 Zhejiang Huahai Pharmaceutical
    • 2.5.1 Zhejiang Huahai Pharmaceutical Details
    • 2.5.2 Zhejiang Huahai Pharmaceutical Major Business
    • 2.5.3 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Product and Services
    • 2.5.4 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
  • 2.6 Apino Pharma
    • 2.6.1 Apino Pharma Details
    • 2.6.2 Apino Pharma Major Business
    • 2.6.3 Apino Pharma Suvorexant Tablet Product and Services
    • 2.6.4 Apino Pharma Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Apino Pharma Recent Developments/Updates
  • 2.7 Guangzhou Green Cross Pharmaceutical
    • 2.7.1 Guangzhou Green Cross Pharmaceutical Details
    • 2.7.2 Guangzhou Green Cross Pharmaceutical Major Business
    • 2.7.3 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Product and Services
    • 2.7.4 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
  • 2.8 Sandoo Pharmaceuticals and Chemicals
    • 2.8.1 Sandoo Pharmaceuticals and Chemicals Details
    • 2.8.2 Sandoo Pharmaceuticals and Chemicals Major Business
    • 2.8.3 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Product and Services
    • 2.8.4 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
  • 2.9 Nanjing Wedo Pharmatech
    • 2.9.1 Nanjing Wedo Pharmatech Details
    • 2.9.2 Nanjing Wedo Pharmatech Major Business
    • 2.9.3 Nanjing Wedo Pharmatech Suvorexant Tablet Product and Services
    • 2.9.4 Nanjing Wedo Pharmatech Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Nanjing Wedo Pharmatech Recent Developments/Updates
  • 2.10 Unibest Industrial
    • 2.10.1 Unibest Industrial Details
    • 2.10.2 Unibest Industrial Major Business
    • 2.10.3 Unibest Industrial Suvorexant Tablet Product and Services
    • 2.10.4 Unibest Industrial Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Unibest Industrial Recent Developments/Updates
  • 2.11 Taizhou Sci-Healthoo Pharmaceutical Technology
    • 2.11.1 Taizhou Sci-Healthoo Pharmaceutical Technology Details
    • 2.11.2 Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
    • 2.11.3 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Product and Services
    • 2.11.4 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
  • 2.12 Shanghai Haoyuan Chemexpress
    • 2.12.1 Shanghai Haoyuan Chemexpress Details
    • 2.12.2 Shanghai Haoyuan Chemexpress Major Business
    • 2.12.3 Shanghai Haoyuan Chemexpress Suvorexant Tablet Product and Services
    • 2.12.4 Shanghai Haoyuan Chemexpress Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shanghai Haoyuan Chemexpress Recent Developments/Updates

3 Competitive Environment: Suvorexant Tablet by Manufacturer

  • 3.1 Global Suvorexant Tablet Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Suvorexant Tablet Revenue by Manufacturer (2021-2026)
  • 3.3 Global Suvorexant Tablet Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Suvorexant Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Suvorexant Tablet Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Suvorexant Tablet Manufacturer Market Share in 2025
  • 3.5 Suvorexant Tablet Market: Overall Company Footprint Analysis
    • 3.5.1 Suvorexant Tablet Market: Region Footprint
    • 3.5.2 Suvorexant Tablet Market: Company Product Type Footprint
    • 3.5.3 Suvorexant Tablet Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Suvorexant Tablet Market Size by Region
    • 4.1.1 Global Suvorexant Tablet Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Suvorexant Tablet Consumption Value by Region (2021-2032)
    • 4.1.3 Global Suvorexant Tablet Average Price by Region (2021-2032)
  • 4.2 North America Suvorexant Tablet Consumption Value (2021-2032)
  • 4.3 Europe Suvorexant Tablet Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Suvorexant Tablet Consumption Value (2021-2032)
  • 4.5 South America Suvorexant Tablet Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Suvorexant Tablet Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Suvorexant Tablet Sales Quantity by Type (2021-2032)
  • 5.2 Global Suvorexant Tablet Consumption Value by Type (2021-2032)
  • 5.3 Global Suvorexant Tablet Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Suvorexant Tablet Sales Quantity by Application (2021-2032)
  • 6.2 Global Suvorexant Tablet Consumption Value by Application (2021-2032)
  • 6.3 Global Suvorexant Tablet Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Suvorexant Tablet Sales Quantity by Type (2021-2032)
  • 7.2 North America Suvorexant Tablet Sales Quantity by Application (2021-2032)
  • 7.3 North America Suvorexant Tablet Market Size by Country
    • 7.3.1 North America Suvorexant Tablet Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Suvorexant Tablet Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Suvorexant Tablet Sales Quantity by Type (2021-2032)
  • 8.2 Europe Suvorexant Tablet Sales Quantity by Application (2021-2032)
  • 8.3 Europe Suvorexant Tablet Market Size by Country
    • 8.3.1 Europe Suvorexant Tablet Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Suvorexant Tablet Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Suvorexant Tablet Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Suvorexant Tablet Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Suvorexant Tablet Market Size by Region
    • 9.3.1 Asia-Pacific Suvorexant Tablet Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Suvorexant Tablet Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Suvorexant Tablet Sales Quantity by Type (2021-2032)
  • 10.2 South America Suvorexant Tablet Sales Quantity by Application (2021-2032)
  • 10.3 South America Suvorexant Tablet Market Size by Country
    • 10.3.1 South America Suvorexant Tablet Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Suvorexant Tablet Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Suvorexant Tablet Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Suvorexant Tablet Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Suvorexant Tablet Market Size by Country
    • 11.3.1 Middle East & Africa Suvorexant Tablet Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Suvorexant Tablet Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Suvorexant Tablet Market Drivers
  • 12.2 Suvorexant Tablet Market Restraints
  • 12.3 Suvorexant Tablet Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Suvorexant Tablet and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Suvorexant Tablet
  • 13.3 Suvorexant Tablet Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Suvorexant Tablet Typical Distributors
  • 14.3 Suvorexant Tablet Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Suvorexant Tablet market size was valued at US$ 376 million in 2025 and is forecast to a readjusted size of US$ 270 million by 2032 with a CAGR of -4.7% during review period.
    Suvorexant (brand name Belsomra) is a prescription medication used to treat insomnia, specifically helping adults fall asleep faster and stay asleep longer. It acts as a dual orexin receptor antagonist, blocking chemicals in the brain that promote wakefulness. It is taken orally, typically at a dose of 10-20 mg, 30 minutes before bed.
    In 2025, the global production of Suvoresin tablets is 46.2 million tablets, with an average price of US$7.9 per tablet and an average gross profit margin of 81%.
    Based on our research, the suvorexant market should be characterized as a highly focused single-molecule prescription drug market rather than a broad insomnia treatment segment. The appropriate scope is limited to finished oral tablets containing suvorexant and its associated supply chain, excluding other DORA drugs and traditional hypnotics. From a product perspective, suvorexant represents the first commercially successful dual orexin receptor antagonist, but its commercial performance remains heavily dependent on the BELSOMRA franchise rather than a multi-manufacturer expansion model.
    From a supply structure standpoint, the finished dosage market remains highly concentrated, with Merck/MSD as the dominant player. Regional entities in Japan and Australia operate under the same corporate system, reinforcing the centralized nature of the finished drug segment. In contrast, the upstream API and intermediate supply chain is more diversified, with increasing participation from Chinese companies, particularly in custom synthesis, intermediate manufacturing, and potential generic pathways. This creates a dual-layer structure characterized by concentrated downstream commercialization and fragmented upstream supply.
    From a demand perspective, suvorexant faces both structural support and competitive pressure. The DORA mechanism offers clinical advantages over traditional hypnotics, supporting its role in premium insomnia treatment. However, competing products such as lemborexant and daridorexant exert direct pressure on market share. As a result, while baseline demand is expected to remain stable, pricing dynamics and revenue growth are likely to weaken over time.
    From a regulatory perspective, suvorexant operates under stricter frameworks compared to standard oral drugs, including controlled substance classification in the United States and additional prescription controls in other regions. These regulatory factors increase entry barriers for generics and suppliers, requiring not only chemical manufacturing capability but also compliance with regulatory, quality, and distribution requirements. Over time, the industry is expected to evolve from a single-originator model to a layered ecosystem involving originators, generic entrants, API suppliers, and specialized intermediate manufacturers.
    This report is a detailed and comprehensive analysis for global Suvorexant Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Suvorexant Tablet market size and forecasts, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
    Global Suvorexant Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
    Global Suvorexant Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
    Global Suvorexant Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (K Tablets), and ASP (US$/Tablet), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Suvorexant Tablet
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Suvorexant Tablet market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., MSD K.K., Merck Sharp & Dohme (Australia), Axplora Group, Zhejiang Huahai Pharmaceutical, Apino Pharma, Guangzhou Green Cross Pharmaceutical, Sandoo Pharmaceuticals and Chemicals, Nanjing Wedo Pharmatech, Unibest Industrial, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Suvorexant Tablet market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    5 mg Tablets
    10 mg Tablets
    15 mg Tablets
    20 mg Tablets
    Other
    Market segment by Regulatory Status
    Approved Originator Product
    Approved Generic Product
    Generic Under Filing
    Market segment by Application
    Sleep Onset Insomnia
    Sleep Maintenance Insomnia
    Mixed Insomnia
    Clinical Research
    Other
    Major players covered
    Merck & Co.
    MSD K.K.
    Merck Sharp & Dohme (Australia)
    Axplora Group
    Zhejiang Huahai Pharmaceutical
    Apino Pharma
    Guangzhou Green Cross Pharmaceutical
    Sandoo Pharmaceuticals and Chemicals
    Nanjing Wedo Pharmatech
    Unibest Industrial
    Taizhou Sci-Healthoo Pharmaceutical Technology
    Shanghai Haoyuan Chemexpress
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Suvorexant Tablet product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Suvorexant Tablet, with price, sales quantity, revenue, and global market share of Suvorexant Tablet from 2021 to 2026.
    Chapter 3, the Suvorexant Tablet competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Suvorexant Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Suvorexant Tablet market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Suvorexant Tablet.
    Chapter 14 and 15, to describe Suvorexant Tablet sales channel, distributors, customers, research findings and conclusion.

    Buy now